Indian branded pharma Sector sees a decline in growth: Report Farhat Nasim9 Oct 2024 6:54 PM ISTCompanies such as Dr Reddys Laboratories (DRRD), Zydus Lifesciences (ZYDUSLIF), Lupin (LPC), and Mankind Pharma (MANKIND) expected to outperform on a...
Medical Bulletin 07/ October/ 2024 Dr. Bhumika Maikhuri7 Oct 2024 3:00 PM ISTHere are the top medical news for the day:Want to Prevent Back Pain? Reduce Sitting TimeA new study from the University of Turku in Finland showed...
WHO recommends maternal vaccine and antibody shot for preventing RSV in infants Dr. Bhumika Maikhuri7 Oct 2024 8:45 AM ISTThe World Health Organization recommended vaccinating pregnant women and administering infants with an antibody to prevent severe respiratory synctial...
FDA approves first biologic treatment for COPD Dr. Kamal Kant Kohli3 Oct 2024 7:30 AM ISTThe US Food and Drug Administration has approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic obstructive pulmonary...
Sanofi, Regeneron get USFDA nod for Dupixent for COPD Ruchika Sharma29 Sept 2024 12:30 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance treatment...
USFDA nod to Sanofi Sarclisa in combo with bortezomib, lenalidomide, dexamethasone for newly diagnosed multiple myeloma not eligible for transpant Ruchika Sharma21 Sept 2024 2:25 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has approved Sarclisa (isatuximab) in combination with bortezomib,...
Sanofi Consumer Healthcare makes debut on BSE, NSE MD Bureau Team14 Sept 2024 1:59 PM ISTNew Delhi: Sanofi Consumer Healthcare India on Friday said it has been listed on the BSE and the National Stock Exchange.Sanofi Consumer Healthcare...
Sanofi, RadioMedix, Orano Med enter licensing agreement on next-generation radioligand medicine for rare cancers Ruchika Sharma12 Sept 2024 2:28 PM ISTParis: Sanofi has entered into an exclusive licensing agreement with RadioMedix, Inc., a US clinical-stage biotechnology company developing...
CDSCO Panel Approves Sanofi's Protocol Amendment proposal for Fitusiran study Dr. Divya Colin7 Sept 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Submit clinical study data conducted in adults: CDSCO Panel Tells Sanofi on atopic dermatitis drug Dr. Divya Colin4 Aug 2024 6:00 PM ISTNew Delhi: Responding to the protocol amendment proposal for Amlitelimab study, the Subject Expert Committee (SEC) functional under the Central Drug...
Sanofi gets CDSCO marketing nod for RSV treatment Beyfortus in India Ruchika Sharma1 Aug 2024 5:30 PM ISTDrugmaker, Sanofi India, has received marketing authorisation approval from the Central Drugs Standard Control Organisation (CDSCO) for Beyfortus in...
Duchenne muscular dystrophy: Sanofi owned biotech company sues Sarepta Therapeutics over patent infringement Ruchika Sharma31 July 2024 4:02 PM ISTSanofi-owned biotech company Genzyme has initiated a lawsuit against competitor Sarepta Therapeutics in Delaware federal court, accusing the firm of...
